Literature DB >> 194920

Isolation and characterization of an abnormal high density lipoprotein in Tangier Diesase.

G Assmann, P N Herbert, D S Fredrickson, T Forte.   

Abstract

The nature of the high density lipoproteins has been investigated in five patients homozygous for Tangier disease (familial high density lipoprotein deficiency). It has been established that Tangier high density lipoproteins, as isolated by ultracentrifugation, are morphologically heterogenous and contain several proteins (Apo B, albumin, and Apo A-II). An abnormal lipoprotein has been isolated from the d = 1.063-1.21 g/ml ultracentrifugal fraction by agarose-column chromatography which contains apoprotein A-II as the sole protein constituent. In negative-stain electron microscopy, these lipoproteins appeared as spherical particles 55-75 A in diameter. By a variety of criteria (immunochemical, polyacrylamide electrophoresis, amino acid composition, and fluorescence measurements), apoprotein A-I the major apoprotein of normal high density lipoproteins and the C apoproteins were absent from this lipoprotein. As demonstrated by (125)I very low density lipoprotein incubation experiments with Tangier plasma, C apoproteins did not associate with lipoproteins of d = 1.063-1.21 g/ml. Tangier apoprotein A-II, isolated to homogeneity by delipidation of the apoprotein A-II-containing lipoprotein or Sephadex G-200 guanidine-HCl chromatography of the d = 1.063-1.21 g/ml fraction, was indistinguishable from control apoprotein A-II with respect to amino acid composition and migration of tryptic peptides in urea-polyacrylamide electrophoresis. The ability of Tangier apoprotein A-II to bind phospholipid was demonstrated by in vitro reconstitution experiments and morphological and chemical analysis of lipid-protein complexes. It is concluded that normal high density lipoproteins, as defined by polypeptide composition and morphological appearance, are absent from Tangier plasma and that as a consequence, the impairment of C apoprotein metabolism contributes to the hypertriglyceridemia and fasting chylomicronemia observed in these patients.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 194920      PMCID: PMC372362          DOI: 10.1172/JCI108761

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

1.  THE INHERITANCE OF HIGH DENSITY LIPOPROTEIN DEFICIENCY (TANGIER DISEASE).

Authors:  D S FREDRICKSON
Journal:  J Clin Invest       Date:  1964-02       Impact factor: 14.808

2.  Rapid estimation of free and total cholesterol.

Authors:  B ZAK; R C DICKENMAN; E G WHITE; H BURNETT; P J CHERNEY
Journal:  Am J Clin Pathol       Date:  1954-11       Impact factor: 2.493

3.  The pathology of Tangier disease. A light and electron microscopic study.

Authors:  V J Ferrans; D S Fredrickson
Journal:  Am J Pathol       Date:  1975-01       Impact factor: 4.307

4.  An abnormal high density lipoprotein in cholestatic plasma isolated by zonal ultracentrifugation.

Authors:  B Danielsson; R Ekman; B G Petersson
Journal:  FEBS Lett       Date:  1975-02-01       Impact factor: 4.124

5.  Lipoproteins in lecithin-cholesterol-acyltransferase(LCAT)-deficiency. II. Further studies on the abnormal high-density-lipoproteins.

Authors:  G Utermann; H J Menzel; K H Langer; P Dieker
Journal:  Humangenetik       Date:  1975

6.  Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: effects of incubation with lecithin: cholesterol acyltransferase in vitro.

Authors:  K R Norum; J A Glomset; A V Nichols; T Forte; J J Albers; W C King; C D Mitchell; K R Applegate; E L Gong; V Cabana
Journal:  Scand J Clin Lab Invest Suppl       Date:  1975

7.  The lipoprotein abnormality in Tangier disease: quantitation of A apoproteins.

Authors:  G Assmann; E Smootz; K Adler; A Capurso; K Oette
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

8.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

9.  Electrophoretic heterogeneity of polypeptide chains of specific antibodies.

Authors:  R A Reisfeld; P A Small
Journal:  Science       Date:  1966-05-27       Impact factor: 47.728

10.  Discoidal bilayer structure of nascent high density lipoproteins from perfused rat liver.

Authors:  R L Hamilton; M C Williams; C J Fielding; R J Havel
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

View more
  20 in total

1.  Characterization of high density lipoproteins in patients heterozygous for Tangier disease.

Authors:  G Assmann; O Simantke; H E Schaefer; E Smootz
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

2.  Properties of the plasma very low and low density lipoproteins in Tangier disease.

Authors:  R J Heinen; P N Herbert; D S Fredrickson
Journal:  J Clin Invest       Date:  1978-01       Impact factor: 14.808

3.  Very low density lipoprotein. Metabolism of phospholipids, cholesterol, and apolipoprotein C in the isolated perfused rat heart.

Authors:  T Chajek; S Eisenberg
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

4.  [Tangier-disease (author's transl)].

Authors:  G Assmann
Journal:  Klin Wochenschr       Date:  1979-01-15

5.  Tangier disease: heterozygote detection and linkage analysis.

Authors:  B K Suarez; G Schonfeld; R S Sparkes
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

6.  Amelioration of cholesterol induced atherosclerosis by normalizing gene expression, cholesterol profile and antioxidant enzymes by Vigna unguiculata.

Authors:  P A Janeesh; Annie Abraham
Journal:  Plant Foods Hum Nutr       Date:  2013-06       Impact factor: 3.921

7.  Tangier disease: defective recombination of a specific Tangier apolipoprotein A-I isoform (pro-apo A-i) with high density lipoproteins.

Authors:  G Schmitz; G Assmann; S C Rall; R W Mahley
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

8.  Characterization of apolipoprotein A-I- and A-II-containing lipoproteins in a new case of high density lipoprotein deficiency resembling Tangier disease and their effects on intracellular cholesterol efflux.

Authors:  M C Cheung; A J Mendez; A C Wolf; R H Knopp
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

9.  Familial apolipoprotein AI and apolipoprotein CIII deficiency. Subclass distribution, composition, and morphology of lipoproteins in a disorder associated with premature atherosclerosis.

Authors:  T M Forte; A V Nichols; R M Krauss; R A Norum
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

10.  A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family.

Authors:  G Franceschini; C R Sirtori; A Capurso; K H Weisgraber; R W Mahley
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.